Belogent ointment 15g

Release form

Ointment for external use

Packaging

Tube 15 g.

pharmachologic effect

Anti-inflammatory, anti-allergic, antibacterial, antipruritic.

Belogent has anti-inflammatory, anti-allergic, anti-proliferative and antipruritic effects.

When Belogent is applied to the surface of the skin, it has a quick and strong effect in the inflammation focus, reducing the severity of objective symptoms (erythema, edema, lichenification) and subjective sensations (itching, irritation, pain).

Indications

Dermatoses, allergic and inflammatory skin diseases that respond to topical corticosteroid therapy, the course of which is complicated by a bacterial infection or there is a danger of its addition in children from 1 year of age and in adults:

eczema, diffuse neurodermatitis

dermatitis - atopic, contact (including professional), allergic, seborrheic

Infected dermatitis resulting from insect bites

impetigo

psoriasis

lichen planus

phleboderma

anogenital itching.

Contraindications

hypersensitivity to betamethasone, gentamicin and other components of Belogent

viral skin infections, skin post-vaccination reactions

open wounds, trophic ulcers

acne vulgaris, rosacea

chickenpox

cutaneous manifestations of syphilis

lupus.

Application during pregnancy and lactation

Perhaps if the expected effect of therapy outweighs the potential risk to the fetus.

During pregnancy, the use of Belogent should not be prolonged and, if possible, be limited to small areas of the skin.

During breastfeeding - only for strict indications, but you cannot apply Belogent to the mammary gland before feeding.

special instructions

Belogent is intended for external use only.

Long-term use of the drug on the skin of the face is not recommended.

development of rosacea, perioral dermatitis and acne is possible.

Belogent should not be used in the eye area, due to the likelihood of getting the drug on the mucous membrane, which can contribute to the development of cataracts, glaucoma, fungal eye infections and exacerbation of herpes infection.

Structure

1 g contains 0.64 mg betamethasone dipropionate (corresponding to 0.5 mg betamethasone), gentamicin sulfate (calculated as base) 1 mg

Method of administration and dosage

Belogen is applied to the affected area of ​​the skin with a thin layer, rubbing slightly, 2 times a day.

Side effects

They are mild.

Rarely (as with the use of other GCS), hypersensitivity reactions (burning, itching, redness), acne-like changes, hypopigmentation, striae, skin atrophy, hypertrichosis, telangiectasia may develop.

If hypersensitivity reactions occur, therapy should be discontinued and a doctor should be consulted.

Storage conditions

In a dry, dark place at a temperature not exceeding 25 ° C.

Shelf life

4 years.

Active substance

Betamethasone, Gentamicin

Possible product names

BELOGENT 15.0 OINTMENT BELOGENT 15G.

OINTMENT Belogent ointment, 15 g BELOGENT OINTMENT 15g Belogent ointment for external approx.

15g Tube

Name ENG

BELOGENT

Clinical and pharmacological group

Drug with antibacterial and anti-inflammatory action for external use

ATX code

Betamethasone in combination with antibiotics

Dosage

0.05% + 0.1% x 15g

Structure

1 g of ointment contains betamethasone dipropionate 0.64 mg (corresponds to 0.5 mg betamethasone), gentamicin sulfate (in terms of base) 1 mg, excipients: chlorocresol, sodium dihydrogen phosphate monohydrate, phosphoric acid, soft white paraffin, liquid paraffin, macrogol cetostearate, cetostearyl alcohol [60% cetyl alcohol, 40% stearyl alcohol], sodium hydroxide, water.

Indications

Dermatoses, allergic and inflammatory skin diseases that respond to topical corticosteroid therapy, the course of which is complicated by a bacterial infection or there is a danger of its addition in children from 1 year of age and in adults:

eczema, diffuse neurodermatitis

dermatitis atopic, contact (including professional), allergic, seborrheic

Infected dermatitis resulting from insect bites

impetigo

psoriasis

lichen planus

phleboderma

anogenital itching.

Contraindications

Hypersensitivity to betamethasone, gentamicin and other components of Belogent

viral skin infections, skin post-vaccination reactions

open wounds, trophic ulcers

acne vulgaris, rosacea

chickenpox

cutaneous manifestations of syphilis

lupus.

INN / Active ingredient

betamethasone, gentamicin (sulfate form)

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 4 years

Specifications

Category

Psoriasis

Scope of the drug

Leather

Release form

Ointment

Manufacturer country

Croatia

Package quantity, pcs

one

Minimum age from

1 year

Way of introduction

Locally

,

On the skin

,

Outwardly

Vacation conditions

Without recipe

Brand name

Belupo

The amount of the dosage form in the primary package

15 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

D07CC01 Betamethasone, in combination with antibiotics

Dosage form

Ointment for external use

Expiration date in days

1095

The target audience

Children

Package weight, g

25

Mode of application

:

Outwardly, Belogent ointment is applied to the affected area of ​​the skin with a thin layer, gently rubbing, 2 times a day.

Pharmaco-therapeutic group

:

Topical glucocorticosteroid + antibiotic aminoglycoside

Dosage (volume) of the substance in the preparation

:

betamethasone dipropionate 0.64 mg (corresponds to 0.5 mg of betamethasone), gentamicin sulfate (in terms of base) 1 mg

Information on technical characteristics, delivery set, country of manufacture